Pathogenic profiles and lower respiratory tract microbiota in severe pneumonia patients using metagenomic next-generation sequencing

Abstract

Introduction

The homeostatic balance of the lung microbiota is important for the maintenance of normal physiological function of the lung, but its role in pathological processes such as severe pneumonia is poorly understood.

Methods

We screened 34 patients with community-acquired pneumonia (CAP) and 12 patients with hospital-acquired pneumonia (HAP), all of whom were admitted to the respiratory intensive care unit. Clinical samples, including bronchoalveolar lavage fluid (BALF), sputum, peripheral blood, and tissue specimens, were collected along with traditional microbiological test results, routine clinical test data, and clinical treatment information. The pathogenic spectrum of lower respiratory tract pathogens in critically ill respiratory patients was characterized through metagenomic next-generation sequencing (mNGS). Additionally, we analyzed the composition of the commensal microbiota and its correlation with clinical characteristics.

Results

The sensitivity of the mNGS test for pathogens was 92.2% and the specificity 71.4% compared with the clinical diagnosis of the patients. Using mNGS, we detected more fungi and viruses in the lower respiratory tract of CAP-onset severe pneumonia patients, whereas bacterial species were predominant in HAP-onset patients. On the other hand, using mNGS data, commensal microorganisms such as Fusobacterium yohimbe were observed in the lower respiratory tract of patients with HAP rather than those with CAP, and most of these commensal microorganisms were associated with hospitalization or the staying time in ICU, and were significantly and positively correlated with the total length of stay.

Conclusion

mNGS can be used to effectively identify pathogenic pathogens or lower respiratory microbiome associated with pulmonary infectious diseases, playing a crucial role in the early and accurate diagnosis of these conditions. Based on the findings of this study, it is possible that a novel set of biomarkers and predictive models could be developed in the future to efficiently identify the cause and prognosis of patients with severe pneumonia.

Keywords

CAP / HAP / mNGS / Pathogen Spectrum / Microbiota / Medical and Health Sciences / Clinical Sciences

References

[1] AoZ, XuH, LiM, LiuH, DengM, LiuY. Clinical characteristics, diagnosis, outcomes and lung microbiome analysis of invasive pulmonary aspergillosis in the community-acquired pneumonia patients. BMJ Open Respir Res, 2023, 10. e001358

[2] BingulaR, FilaireE, MolnarI, DelmasE, BerthonJ-Y, VassonM-P, et al. . Characterisation of microbiota in saliva, bronchoalveolar lavage fluid, non-malignant, peritumoural and tumour tissue in non-small cell lung cancer patients: a cross-sectional clinical trial. Respir Res, 2020, 21: 129.

[3] BoersSA, JansenR, HaysJP. Understanding and overcoming the pitfalls and biases of next-generation sequencing (NGS) methods for use in the routine clinical microbiological diagnostic laboratory. Eur J Clin Microbiol Infect Dis, 2019, 38: 1059-1070.

[4] CharlsonES, DiamondJM, BittingerK, FitzgeraldAS, YadavA, HaasAR, et al. . Lung-enriched organisms and aberrant bacterial and fungal respiratory microbiota after lung transplant. Am J Respir Crit Care Med, 2012, 186: 536-545.

[5] ChenW, LiuG, CuiL, TianF, ZhangJ, ZhaoJ, et al. . Evaluation of metagenomic and pathogen-targeted next-generation sequencing for diagnosis of meningitis and encephalitis in adults: A multicenter prospective observational cohort study in China. J Infect, 2024, 88. 106143

[6] ChiuCY, MillerSA. Clinical metagenomics. Nat Rev Genet, 2019, 20: 341-355.

[7] De PascaleG, De MaioF, CarelliS, De AngelisG, CacaciM, MontiniL, et al. . Staphylococcus aureus ventilator-associated pneumonia in patients with COVID-19: clinical features and potential inference with lung dysbiosis. Crit Care, 2021, 25: 197.

[8] DevarajS, HemarajataP, VersalovicJ. The human gut microbiome and body metabolism: implications for obesity and diabetes. Clin Chem, 2013, 59: 617-628.

[9] DicksonRP, Erb-DownwardJR, HuffnagleGB. Towards an ecology of the lung: new conceptual models of pulmonary microbiology and pneumonia pathogenesis. Lancet Respir Med, 2014, 2: 238-246.

[10] DicksonRP, Erb-DownwardJR, MartinezFJ, HuffnagleGB. The Microbiome and the Respiratory Tract. Annu Rev Physiol, 2016, 78: 481-504.

[11] DingL, LiuY, WuX, WuM, LuoX, OuyangH, et al. . Pathogen Metagenomics Reveals Distinct Lung Microbiota Signatures Between Bacteriologically Confirmed and Negative Tuberculosis Patients. Front Cell Infect Microbiol, 2021, 11. 708827

[12] FennD, Abdel-AzizMI, van OortPMP, BrinkmanP, AhmedWM, FeltonT, et al. . Composition and diversity analysis of the lung microbiome in patients with suspected ventilator-associated pneumonia. Crit Care, 2022, 26: 203.

[13] FileTM, RamirezJA. Community-Acquired Pneumonia. N Engl J Med, 2023, 389: 632-641.

[14] GBD 2021 Lower Respiratory Infections and Antimicrobial Resistance Collaborators. Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021. Lancet Infect Dis, 2024, 24: 974-1002.

[15] GuoY, YuanW, LyuN, PanY, CaoX, WangY, et al. . Association Studies on Gut and Lung Microbiomes in Patients with Lung Adenocarcinoma. Microorganisms, 2023, 11: 546.

[16] HanadaS, PirzadehM, CarverKY, DengJC. Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia. Front Immunol, 2018, 9: 2640.

[17] HeY, FangK, ShiX, YangD, ZhaoL, YuW, et al. . Enhanced DNA and RNA pathogen detection via metagenomic sequencing in patients with pneumonia. J Transl Med, 2022, 20: 195.

[18] HérivauxA, GonçalvesSM, CarvalhoA, CunhaC. Microbiota-derived metabolites as diagnostic markers for respiratory fungal infections. J Pharm Biomed Anal, 2020, 189. 113473

[19] HérivauxA, WillisJR, MercierT, LagrouK, GonçalvesSM, GonçalesRA, et al. . Lung microbiota predict invasive pulmonary aspergillosis and its outcome in immunocompromised patients. Thorax, 2022, 77: 283-291.

[20] HiltyM, BurkeC, PedroH, CardenasP, BushA, BossleyC, et al. . Disordered microbial communities in asthmatic airways. PLoS ONE, 2010, 5. e8578

[21] HoganCA, YangS, GarnerOB, GreenDA, GomezCA, Dien BardJ, et al. . Clinical Impact of Metagenomic Next-Generation Sequencing of Plasma Cell-Free DNA for the Diagnosis of Infectious Diseases: A Multicenter Retrospective Cohort Study. Clin Infect Dis, 2021, 72: 239-245.

[22] IntegrativeHMP. (iHMP) Research Network Consortium. The Integrative Human Microbiome Project Nature, 2019, 569: 641-648.

[23] JiangL, HanL, ZhongY, ZhangM, LiJ, RaoG, et al. . High utility of bronchoalveolar lavage fluid metagenomic next-generation sequencing approach for etiological diagnosis of pneumonia. BMC Infect Dis, 2024, 24: 1232.

[24] JinX, LiJ, ShaoM, LvX, JiN, ZhuY, et al. . Improving Suspected Pulmonary Infection Diagnosis by Bronchoalveolar Lavage Fluid Metagenomic Next-Generation Sequencing: a Multicenter Retrospective Study. Microbiol Spectr, 2022, 10. e0247321

[25] LanksCW, MusaniAI, HsiaDW. Community-acquired Pneumonia and Hospital-acquired Pneumonia. Med Clin North Am, 2019, 103: 487-501.

[26] LiY, SunB, TangX, LiuY-L, HeH-Y, LiX-Y, et al. . Application of metagenomic next-generation sequencing for bronchoalveolar lavage diagnostics in critically ill patients. Eur J Clin Microbiol Infect Dis, 2020, 39: 369-374.

[27] LiangM, FanY, ZhangD, YangL, WangX, WangS, et al. . Metagenomic next-generation sequencing for accurate diagnosis and management of lower respiratory tract infections. Int J Infect Dis, 2022, 122: 921-929.

[28] LiaoH, ZhangY, GuoW, WangX, WangH, YeH, et al. . Characterization of the Blood and Cerebrospinal Fluid Microbiome in Children with Bacterial Meningitis and Its Potential Correlation with Inflammation. mSystems, 2021, 6: e0004921.

[29] LipumaJJ. The changing microbial epidemiology in cystic fibrosis. Clin Microbiol Rev, 2010, 23: 299-323.

[30] LiPumaJJ. Expanding our understanding of respiratory microbiota in cystic fibrosis. Ann Am Thorac Soc, 2014, 11: 1084-1085.

[31] LiuC, WuK, SunT, ChenB, YiY, RenR, et al. . Effect of invasive mechanical ventilation on the diversity of the pulmonary microbiota. Crit Care, 2022, 26: 252.

[32] LiuY-N, ZhangY-F, XuQ, QiuY, LuQ-B, WangT, et al. . Infection and co-infection patterns of community-acquired pneumonia in patients of different ages in China from 2009 to 2020: a national surveillance study. Lancet Microbe, 2023, 4: e330-e339.

[33] LiuM, ZhangH, LiL, MaoJ, LiR, YinJ, et al. . The etiological diagnostic value of metagenomic next-generation sequencing in suspected community-acquired pneumonia. BMC Infect Dis, 2024, 24: 626.

[34] ManWH, de Steenhuijsen PitersWAA, BogaertD. The microbiota of the respiratory tract: gatekeeper to respiratory health. Nat Rev Microbiol, 2017, 15: 259-270.

[35] Martin-LoechesI, DicksonR, TorresA, HanbergerH, LipmanJ, AntonelliM, et al. . The importance of airway and lung microbiome in the critically ill. Crit Care, 2020, 24: 537.

[36] MartinsenEMH, EaganTML, LeitenEO, HaalandI, HusebøGR, KnudsenKS, et al. . The pulmonary mycobiome-A study of subjects with and without chronic obstructive pulmonary disease. PLoS ONE, 2021, 16. e0248967

[37] MerensteinC, LiangG, WhitesideSA, Cobián-GüemesAG, MerlinoMS, TaylorLJ, et al. . Signatures of COVID-19 Severity and Immune Response in the Respiratory Tract Microbiome. mBio., 2021, 12: e0177721.

[38] MiaoQ, MaY, WangQ, PanJ, ZhangY, JinW, et al. . Microbiological Diagnostic Performance of Metagenomic Next-generation Sequencing When Applied to Clinical Practice. Clin Infect Dis, 2018, 67: S231-S240.

[39] MoffattMF, CooksonWO. The lung microbiome in health and disease. Clin Med (Lond), 2017, 17: 525-529.

[40] NarendrakumarL, RayA. Respiratory tract microbiome and pneumonia. Prog Mol Biol Transl Sci, 2022, 192: 97-124.

[41] NataliniJG, SinghS, SegalLN. The dynamic lung microbiome in health and disease. Nat Rev Microbiol, 2023, 21: 222-235.

[42] NieuwdorpM, GilijamsePW, PaiN, KaplanLM. Role of the microbiome in energy regulation and metabolism. Gastroenterology, 2014, 146: 1525-1533.

[43] SamuelsonDR, CharlesTP, de la RuaNM, TaylorCM, BlanchardEE, LuoM, et al. . Analysis of the intestinal microbial community and inferred functional capacities during the host response to Pneumocystis pneumonia. Exp Lung Res, 2016, 42: 425-439.

[44] ShaoJ, MaJ, YuY, ZhangS, WangW, LiW, et al. . A multimodal integration pipeline for accurate diagnosis, pathogen identification, and prognosis prediction of pulmonary infections. Innovation (Camb), 2024, 5. 100648

[45] ShenH, LiuT, ShenM, ZhangY, ChenW, ChenH, et al. . Utilizing metagenomic next-generation sequencing for diagnosis and lung microbiome probing of pediatric pneumonia through bronchoalveolar lavage fluid in pediatric intensive care unit: results from a large real-world cohort. Front Cell Infect Microbiol, 2023, 13: 1200806.

[46] ShiN, LiN, DuanX, NiuH. Interaction between the gut microbiome and mucosal immune system. Mil Med Res, 2017, 4: 14.

[47] StavropoulouE, KantartziK, TsigalouC, KonstantinidisT, VoidarouC, KonstantinidisT, et al. . Unraveling the Interconnection Patterns Across Lung Microbiome, Respiratory Diseases, and COVID-19. Front Cell Infect Microbiol, 2020, 10. 619075

[48] SulaimanI, ChungM, AngelL, TsayJ-CJ, WuBG, YeungST, et al. . Microbial signatures in the lower airways of mechanically ventilated COVID-19 patients associated with poor clinical outcome. Nat Microbiol, 2021, 6: 1245-58.

[49] ThibeaultC, SuttorpN, OpitzB. The microbiota in pneumonia: From protection to predisposition. Sci Transl Med, 2021, 13: eaba0501.

[50] TsayJ-CJ, WuBG, SulaimanI, GershnerK, SchlugerR, LiY, et al. . Lower Airway Dysbiosis Affects Lung Cancer Progression. Cancer Discov, 2021, 11: 293-307.

[51] WolffNS, HugenholtzF, WiersingaWJ. The emerging role of the microbiota in the ICU. Crit Care, 2018, 22: 78.

[52] XiaY, DingX, WangS, RenW. Circadian orchestration of host and gut microbiota in infection. Biol Rev Camb Philos Soc, 2023, 98: 115-131.

[53] XiaoG, CaiZ, GuoQ, YeT, TangY, GuanP, et al. . Insights into the Unique Lung Microbiota Profile of Pulmonary Tuberculosis Patients Using Metagenomic Next-Generation Sequencing. Microbiol Spectr, 2022, 10. e0190121

[54] XueQ, XieY, HeY, YuY, FangG, YuW, et al. . Lung microbiome and cytokine profiles in different disease states of COPD: a cohort study. Sci Rep, 2023, 13: 5715.

[55] YangT, MeiQ, FangX, ZhuS, WangY, LiW, et al. . Clinical Value of Metagenomics Next-Generation Sequencing in Bronchoalveolar Lavage Fluid for Patients with Severe Hospital-Acquired Pneumonia: A Nested Case-Control Study. Infect Drug Resist, 2022, 15: 1505-1514.

[56] ZhangY, ZhengW, NingH, LiuJ, LiF, JuX. Interleukin-6 in blood and bronchoalveolar lavage fluid of hospitalized children with community-acquired pneumonia. Front Pediatr, 2022, 10. 922143

[57] ZhouW, ChenJ, XiZ, ShiY, WangL, LuA. Characteristics of Lung Microbiota in Children’s Refractory Mycoplasma pneumoniae Pneumonia Coinfected with Human Adenovirus B. Can J Infect Dis Med Microbiol, 2022, 2022: 7065890.

[58] Andrade BGN, Cuadrat RRC, Tonetti FR, Kitazawa H, Villena J. The role of respiratory microbiota in the protection against viral diseases: respiratory commensal bacteria as next-generation probiotics for COVID-19. Biosci Microbiota Food Health 2022;41:94–102. https://doi.org/10.12938/bmfh.2022-009.

[59] GBD 2021 Causes of Death Collaborators. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021.  Lancet. 2024;403(10440): 2100–2132. https://doi.org/10.1016/S0140-6736(24)00367-2.

[60] Microbial signatures predictive of short-term prognosis in severe pneumonia - PubMed n.d. https://pubmed.ncbi.nlm.nih.gov/39157177/ (accessed January 23, 2025).

Funding

National Science Foundation(82100096)

RIGHTS & PERMISSIONS

The Author(s)